Penumbra, Inc. (PEN)

209,40 +6,31 (+3,11%) Börsenschluss: 04:00PM EDT

Penumbra, Inc.

One Penumbra Place
Alameda, CA 94502
United States
510 748 3200
https://www.penumbrainc.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 4.200

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Adam Elsesser	Co-Founder, Chairman, President & CEO	601,62k	16,27M	1962
Dr. Arani Bose M.D.	Co-Founder & Director	54k	N/A	1962
Ms. Maggie S. Yuen	Chief Financial Officer	666,04k	N/A	1972
Mr. Lambert Shiu	Chief Accounting Officer	539,94k	579,45k	1980
Ms. Johanna Roberts	Executive VP, General Counsel & Secretary	661,89k	1,08M	1972
Mr. Ben Sorci	Executive Vice President of Operations	N/A	N/A	N/A
Mr. Pankaj Tiwari	Executive VP & Chief Information Officer	N/A	N/A	N/A
Ms. Jee Hamlyn-Harris	Investor Relations Officer	N/A	N/A	N/A
Mr. Ben Tompkins	Executive Vice President of Development	N/A	N/A	N/A
Ms. Gita Barry	President of Immersive Healthcare	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Corporate Governance

Penumbra, Inc.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 9, Vorstand: 6, Shareholderrechte: 7, Kompensation: 7.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.